ATM and breast cancer: By comparison, individuals heterozygous for one of the many reported ATM null mutations have reduced levels of the ATM protein, albeit, these reduced levels do not always appear to fall below the threshold for risk of breast cancer and/or clinical radiosensitivity [8,10,12-18].